| 1. |
中國抗癲癇協會. 癲癇的外科治療// 中國抗癲癇協會. 臨床診療指南-癲癇分冊. 2023修訂版. 北京: 人民衛生出版社, 2023, 66-73.
|
| 2. |
Widjaja E, Jain P, Demoe L, et al. Seizure outcome of pediatric epilepsy surgery: Systematic review and meta-analyses. Neurology, 2020, 94(7): 311-321.
|
| 3. |
Wei Z, Fallah A, Wang Y, et al. Influence of resective extent of epileptogenic tuber on seizure outcome in patients with tuberous sclerosis complex-related epilepsy: a systematic review and meta-analysis. Seizure, 2023, 108: 81-88.
|
| 4. |
Liu S, Yu T, Guan Y, et al. Resective epilepsy surgery in tuberous sclerosis complex: a nationwide multicentre retrospective study from China. Brain, 2020, 143(2): 570-581.
|
| 5. |
Jehi L, Jette N, Kwon CS, et al. Timing of referral to evaluate for epilepsy surgery: Expert Consensus Recommendations from the Surgical Therapies Commission of the International League Against Epilepsy. Epilepsia, 2022, 63(10): 2491-2506.
|
| 6. |
中國抗癲癇協會癲癇中心規范化建設委員會. 癲癇外科術前評估規范(草案). 癲癇雜志, 2020, 6(4): 273-295.
|
| 7. |
中國抗癲癇協會, 中華醫學會神經外科學分會神經生理學組, 中華醫學會神經病學分會癲癇與腦電圖學組, 中國醫師協會神經調控專業委員會. 癲癇外科術前評估中國專家共識(2022版). 中華神經外科雜志, 2022, 38(10): 973-979.
|
| 8. |
Liang S, Fan X, Chen F, et al. Chinese guideline on the application of anti-seizure medications in the perioperative period of supratentorial craniocerebral surgery. Ther Adv Neurol Disord, 2022, 15: 17562864221114357.
|